DGM
GBIO

Darwin Global Management’s Generation Bio GBIO Stock Holding History

Darwin Global Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,074
Closed -$289K – 15
2021
Q2 		$289K Sell
1,074
-20,862
-95% -$6.24M 0.05% 12
2021
Q1 		$6.24M Buy
21,936
+2,217
+11% +$710K 1.22% 7
2020
Q4 		$5.59M Buy
+19,719
New +$6.33M 1.56% 8

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Darwin Global Management's GBIO Position: Q3 2021 in Review

Darwin Global Management sold out of Generation Bio (GBIO) in Q3 2021, closing a stake of 1,074 shares — an estimated $289K sold.

Darwin Global Management first reported a position in GBIO in Q4 2020 and held it in 3 quarters. The position peaked at $6.24M in Q1 2021. 81 funds tracked by Wall St. Rank hold GBIO as of Q3 2021.

  • Darwin Global Management reported no remaining Generation Bio position as of Q3 2021 after selling out during the quarter.
  • Darwin Global Management sold 1,074 Generation Bio shares in Q3 2021, an estimated $289K.
  • Darwin Global Management first reported a position in Generation Bio in Q4 2020 and held it in 3 quarters.
  • Darwin Global Management's Generation Bio position peaked at $6.24M in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Generation Bio as of Q3 2021.

Based on Darwin Global Management's 13F filing for Q3 2021, filed 15 Nov 2021.